166 related articles for article (PubMed ID: 21470596)
41. Synthesis and anti-protozoal activity of novel dihydropyrrolo[3,4-d][1,2,3]triazoles.
Dürüst Y; Karakuş H; Kaiser M; Tasdemir D
Eur J Med Chem; 2012 Feb; 48():296-304. PubMed ID: 22217867
[TBL] [Abstract][Full Text] [Related]
42. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
Gregus Z; Németi B
Toxicol Sci; 2007 Nov; 100(1):44-53. PubMed ID: 17693424
[TBL] [Abstract][Full Text] [Related]
43. Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes.
Martin JL; Veluraja K; Ross K; Johnson LN; Fleet GW; Ramsden NG; Bruce I; Orchard MG; Oikonomakos NG; Papageorgiou AC
Biochemistry; 1991 Oct; 30(42):10101-16. PubMed ID: 1931942
[TBL] [Abstract][Full Text] [Related]
44. Synthesis of substituted-phenyl-1,2,4-triazol-3-thione analogues with modified D-glucopyranosyl residues and their antiproliferative activities.
Li Z; Gu Z; Yin K; Zhang R; Deng Q; Xiang J
Eur J Med Chem; 2009 Nov; 44(11):4716-20. PubMed ID: 19560842
[TBL] [Abstract][Full Text] [Related]
45. The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction.
Baker DJ; Greenhaff PL; MacInnes A; Timmons JA
Diabetes; 2006 Jun; 55(6):1855-61. PubMed ID: 16731853
[TBL] [Abstract][Full Text] [Related]
46. Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase.
Pardin C; Roy I; Lubell WD; Keillor JW
Chem Biol Drug Des; 2008 Sep; 72(3):189-96. PubMed ID: 18715232
[TBL] [Abstract][Full Text] [Related]
47. Synthesis of anomeric sulfonamides and their behaviour under radical-mediated bromination conditions.
Czifrák K; Somsák L
Carbohydr Res; 2009 Feb; 344(3):269-77. PubMed ID: 19084827
[TBL] [Abstract][Full Text] [Related]
48. Efficient atropodiastereoselective access to 5,5'-bis-1,2,3-triazoles: studies on 1-glucosylated 5-halogeno 1,2,3-triazoles and their 5-substituted derivatives as glycogen phosphorylase inhibitors.
Goyard D; Chajistamatiou AS; Sotiropoulou AI; Chrysina ED; Praly JP; Vidal S
Chemistry; 2014 Apr; 20(18):5423-32. PubMed ID: 24677199
[TBL] [Abstract][Full Text] [Related]
49. C-Glucosylated malonitrile as a key intermediate towards carbohydrate-based glycogen phosphorylase inhibitors.
Feuillastre S; Chajistamatiou AS; Potamitis C; Zervou M; Zoumpoulakis P; Chrysina ED; Praly JP; Vidal S
Bioorg Med Chem; 2012 Sep; 20(18):5592-9. PubMed ID: 22910227
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of oleanolic acid dimers as inhibitors of glycogen phosphorylase.
Cheng K; Liu J; Sun H; Xie J
Chem Biodivers; 2010 Mar; 7(3):690-7. PubMed ID: 20232331
[TBL] [Abstract][Full Text] [Related]
51. Glucose-based spiro-heterocycles as potent inhibitors of glycogen phosphorylase.
Nagy V; Benltifa M; Vidal S; Berzsényi E; Teilhet C; Czifrák K; Batta G; Docsa T; Gergely P; Somsák L; Praly JP
Bioorg Med Chem; 2009 Aug; 17(15):5696-707. PubMed ID: 19574053
[TBL] [Abstract][Full Text] [Related]
52. [Synthesis and antibacterial activity of 3-(5-substituted phenyl-[1,3,4] oxadiazole-2-yl-methylenethio)-5-pyridin-3-yl-[1,2,4] triazole-4-yl-amines].
Hu GQ; Xie SQ; Xu QJ; Huang WL; Zhang HB; Huang ST
Yao Xue Xue Bao; 2005 Apr; 40(4):337-9. PubMed ID: 16011262
[TBL] [Abstract][Full Text] [Related]
53. Binding of oxalyl derivatives of beta-d-glucopyranosylamine to muscle glycogen phosphorylase b.
Hadjiloi T; Tiraidis C; Chrysina ED; Leonidas DD; Oikonomakos NG; Tsipos P; Gimisis T
Bioorg Med Chem; 2006 Jun; 14(11):3872-82. PubMed ID: 16464598
[TBL] [Abstract][Full Text] [Related]
54. Synthesis of a C-glucosylated cyclopropylamide and evaluation as a glycogen phosphorylase inhibitor.
Bertus P; Szymoniak J; Jeanneau E; Docsa T; Gergely P; Praly JP; Vidal S
Bioorg Med Chem Lett; 2008 Sep; 18(17):4774-8. PubMed ID: 18701279
[TBL] [Abstract][Full Text] [Related]
55. Dual-Target Compounds against Type 2
Sipos Á; Szennyes E; Hajnal NÉ; Kun S; Szabó KE; Uray K; Somsák L; Docsa T; Bokor É
Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33920838
[TBL] [Abstract][Full Text] [Related]
56. Glucose analog inhibitors of glycogen phosphorylases as potential antidiabetic agents: recent developments.
Somsák L; Nagya V; Hadady Z; Docsa T; Gergely P
Curr Pharm Des; 2003; 9(15):1177-89. PubMed ID: 12769745
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and in vitro characterization of 1-(4-aminofurazan-3-yl)-5-dialkylaminomethyl-1H-[1,2,3]triazole-4-carboxylic acid derivatives. A new class of selective GSK-3 inhibitors.
Olesen PH; Sørensen AR; Ursø B; Kurtzhals P; Bowler AN; Ehrbar U; Hansen BF
J Med Chem; 2003 Jul; 46(15):3333-41. PubMed ID: 12852764
[TBL] [Abstract][Full Text] [Related]
58. [Glycosylation of 5-Phenyl-1,3,4-oxadiazole-2-thiol with alpha-D-glucopyranosyl chloride under phase transfer conditions].
Kur'ianov VO; Kotliar SA; Prisoka US; Chupakhina TA; Chirva VIa
Bioorg Khim; 2006; 32(5):520-3. PubMed ID: 17042269
[TBL] [Abstract][Full Text] [Related]
59. On the rearrangement in dioxane/water of (Z)-arylhydrazones of 5-amino-3-benzoyl-1,2,4-oxadiazole into (2-aryl-5-phenyl-2H-1,2,3-triazol-4-yl)ureas: substituent effects on the different reaction pathways.
D'Anna F; Frenna V; Macaluso G; Marullo S; Morganti S; Pace V; Spinelli D; Spisani R; Tavani C
J Org Chem; 2006 Jul; 71(15):5616-24. PubMed ID: 16839141
[TBL] [Abstract][Full Text] [Related]
60. Synthesis of some novel heterocylic compounds derived from 2-[3-(4-chlorophenyl)-5-(4-methoxybenzyl)-4H-1,2,4-triazol-4-yl]acetohydrazide and investigation of their lipase and α-glucosidase inhibition.
Bekircan O; Ülker S; Menteşe E
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):1002-9. PubMed ID: 25640970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
